Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilvadipine in Mild to Moderate Alzheimer's Disease
NCT02017340Phase 3Completed
- Sponsor
- Prof Brian Lawlor
- Start
- Apr 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of nilvadipine in Alzheimer's disease (AD), sponsored by Prof Brian Lawlor. Started Apr 2013; status: completed.
02
Drugs
nilvadipine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02017340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017340.